Cibc Private Wealth Group, LLC Avidity Biosciences, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $51.3 Billion
- Q1 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 26 shares of RNA stock, worth $925. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26Holding current value
$925% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RNA
# of Institutions
244Shares Held
116MCall Options Held
289KPut Options Held
998K-
Janus Henderson Group PLC London, X011.4MShares$407 Million0.19% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.3MShares$404 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA9.68MShares$345 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.24MShares$329 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY8.75MShares$311 Million4.23% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.86B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...